PlexinA2 mediates osteoblast differentiation via regulation of Runx2

Journal of Bone and Mineral Research

Volumn 27, Issue 3, 2012, Pages 552-562

  Oh, Ji Eun ^a,b   Kim, Hyung Joon ^a   Kim, Woo Shin ^a   Lee, Zang Hee ^a   Ryoo, Hyun Mo ^a   Hwang, Soon Jung ^a   Lee, Youngkyun ^a   Kim, Hong Hee ^a  

^a Seoul National University   (South Korea)

^b Far East University   (South Korea)

Author keywords

AXON GUIDANCE MOLECULE; BMP SIGNALING; OSTEOBLAST DIFFERENTIATION; PLEXINA2; RUNX2

Indexed keywords

ACTIN; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PLEXIN; PLEXINA1; PLEXINA2; PLEXINA3; PLEXINA4; PROTEIN KINASE B; SMAD PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOUSE; NERVE GROWTH; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

3T3 CELLS; ANIMALS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA PRIMERS; HUMANS; MICE; NERVE TISSUE PROTEINS; OSTEOBLASTS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84863129183     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1471     Document Type: Article

References (36)

1. Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M, Hassan MQ, Gaur T, Lengner CJ, Young DW., Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord. 2006; 7: 1-16.
2. Karsenty G, Kronenberg HM, Settembre C., Genetic control of bone formation. Annu Rev Cell Dev Biol. 2009; 25: 629-48.
3. Komori T., Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 2010; 339: 189-95.
4. Miyazono K, Maeda S, Imamura T., BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005; 16: 251-63.
5. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G., Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997; 89: 747-54.
6. Suzuki A, Guicheux J, Palmer G, Miura Y, Oiso Y, Bonjour JP, Caverzasio J., Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone. 2002; 30: 91-8.
7. Mukherjee A, Rotwein P., Akt promotes BMP2-mediated osteoblast differentiation and bone development. J Cell Sci. 2009; 122: 716-26.
8. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG., Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem. 2002; 277: 33361-8.
9. Zhang YE., Non-Smad pathways in TGF-beta signaling. Cell Res. 2009; 19: 128-39.
10. Kruger RP, Aurandt J, Guan KL., Semaphorins command cells to move. Nat Rev Mol Cell Biol. 2005; 6: 789-800.
11. Tamagnone L, Comoglio PM., Signalling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol. 2000; 10: 377-83.
12. Tamagnone L, Giordano S., Semaphorin pathways orchestrate osteogenesis. Nat Cell Biol. 2006; 8: 545-7.
13. Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM., Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem. 2004; 279: 50773-80.
14. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, Sung JH, Wozney JM, Ryoo HM., BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem. 2003; 278: 34387-94.
15. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT., Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res. 1999; 14: 893-903.
16. Huang H, Kim HJ, Chang EJ, Lee ZH, Hwang SJ, Kim HM, Lee Y, Kim HH., IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ. 2009; 16: 1332-43.
17. Garrett IR., Assessing bone formation using mouse calvarial organ cultures. Methods Mol Med. 2003; 80: 183-98.
18. Ha J, Choi HS, Lee Y, Kwon HJ, Song YW, Kim HH., CXC chemokine ligand 2 induced by receptor activator of NF-kappa B ligand enhances osteoclastogenesis. J Immunol. 2010; 184: 4717-24.
19. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G., A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999; 13: 1025-36.
20. Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC., Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature. 1996; 383: 525-8.
21. Kanda T, Yoshida Y, Izu Y, Nifuji A, Ezura Y, Nakashima K, Noda M., PlexinD1 deficiency induces defects in axial skeletal morphogenesis. J Cell Biochem. 2007; 101: 1329-37.
22. Delorme G, Saltel F, Bonnelye E, Jurdic P, Machuca-Gayet I., Expression and function of semaphorin 7A in bone cells. Biol Cell. 2005; 97: 589-97.
23. Takegahara N, Takamatsu H, Toyofuku T, Tsujimura T, Okuno T, Yukawa K, Mizui M, Yamamoto M, Prasad DV, Suzuki K, Ishii M, Terai K, Moriya M, Nakatsuji Y, Sakoda S, Sato S, Akira S, Takeda K, Inui M, Takai T, Ikawa M, Okabe M, Kumanogoh A, Kikutani H., Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat Cell Biol. 2006; 8: 615-22.
24. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S., Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12cells. Bone. 2001; 28: 491-8.
25. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K, Nishida E., Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem. 1999; 274: 27161-7.
26. Lee KS, Hong SH, Bae SC., Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene. 2002; 21: 7156-63.
27. Wang X, Goh CH, Li B., p38 mitogen-activated protein kinase regulates osteoblast differentiation through Osterix. Endocrinology. 2007; 148: 1629-37.
28. Noth U, Tuli R, Seghatoleslami R, Howard M, Shah A, Hall DJ, Hickok NJ, Tuan RS., Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res. 2003; 291: 201-11.
29. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T., Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol. 2004; 166: 85-95.
30. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N., Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 2003; 17: 1352-65.
31. Liu X, Bruxvoort KJ, Zylstra CR, Liu J, Cichowski R, Faugere MC, Bouxsein ML, Wan C, Williams BO, Clemens TL., Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc Natl Acad Sci USA. 2007; 104: 2259-64.
32. Basile JR, Afkhami T, Gutkind JS., Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol. 2005; 25: 6889-98.
33. Lee MH, Kim YJ, Yoon WJ, Kim JI, Kim BG, Hwang YS, Wozney JM, Chi XZ, Bae SC, Choi KY, Cho JY, Choi JY, Ryoo HM., Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem. 2005; 280: 35579-87.
34. Hassan MQ, Tare RS, Lee SH, Mandeville M, Morasso MI, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB., BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J Biol Chem. 2006; 281: 40515-26.
35. Ortuno MJ, Ruiz-Gaspa S, Rodriguez-Carballo E, Susperregui AR, Bartrons R, Rosa JL, Ventura F., p38 regulates expression of osteoblast-specific genes by phosphorylation of Osterix. J Biol Chem. 2010; 285: 31985-94.
36. Elefteriou F., Neuronal signaling and the regulation of bone remodeling. Cell Mol Life Sci. 2005; 62: 2339-49.